CRISPR Falling on Deaf Ears
Gaétan Burgio · The CRISPR Journal · 2018
The use of Class II CRISPR* effector systems to edit the human genome for therapeutic purposes is potentially a game changer due to their versatility, simplicity of use, and relatively low cellular toxicity.